These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Presymptomatic and early pathological features of MAPT-associated frontotemporal lobar degeneration. Giannini LA; Mol MO; Rajicic A; van Buuren R; Sarkar L; Arezoumandan S; Ohm DT; Irwin DJ; Rozemuller AJ; ; van Swieten JC; Seelaar H Acta Neuropathol Commun; 2023 Aug; 11(1):126. PubMed ID: 37533060 [TBL] [Abstract][Full Text] [Related]
27. Regional metabolic changes in the hippocampus and posterior cingulate area detected with 3-Tesla magnetic resonance spectroscopy in patients with mild cognitive impairment and Alzheimer disease. Wang Z; Zhao C; Yu L; Zhou W; Li K Acta Radiol; 2009 Apr; 50(3):312-9. PubMed ID: 19235582 [TBL] [Abstract][Full Text] [Related]
28. Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies. Forrest SL; Kril JJ; Stevens CH; Kwok JB; Hallupp M; Kim WS; Huang Y; McGinley CV; Werka H; Kiernan MC; Götz J; Spillantini MG; Hodges JR; Ittner LM; Halliday GM Brain; 2018 Feb; 141(2):521-534. PubMed ID: 29253099 [TBL] [Abstract][Full Text] [Related]
29. Magnetic resonance spectroscopy performance for detection of dementia, Alzheimer's disease and mild cognitive impairment in a community-based survey. García Santos JM; Gavrila D; Antúnez C; Tormo MJ; Salmerón D; Carles R; Jiménez Veiga J; Parrilla G; Torres del Río S; Fortuna L; Navarro C Dement Geriatr Cogn Disord; 2008; 26(1):15-25. PubMed ID: 18566544 [TBL] [Abstract][Full Text] [Related]
30. Cerebral perfusion changes in presymptomatic genetic frontotemporal dementia: a GENFI study. Mutsaerts HJMM; Mirza SS; Petr J; Thomas DL; Cash DM; Bocchetta M; de Vita E; Metcalfe AWS; Shirzadi Z; Robertson AD; Tartaglia MC; Mitchell SB; Black SE; Freedman M; Tang-Wai D; Keren R; Rogaeva E; van Swieten J; Laforce R; Tagliavini F; Borroni B; Galimberti D; Rowe JB; Graff C; Frisoni GB; Finger E; Sorbi S; de Mendonça A; Rohrer JD; MacIntosh BJ; Masellis M; Brain; 2019 Apr; 142(4):1108-1120. PubMed ID: 30847466 [TBL] [Abstract][Full Text] [Related]
31. Familial globular glial tauopathy linked to MAPT mutations: molecular neuropathology and seeding capacity of a prototypical mixed neuronal and glial tauopathy. Ferrer I; Andrés-Benito P; Zelaya MV; Aguirre MEE; Carmona M; Ausín K; Lachén-Montes M; Fernández-Irigoyen J; Santamaría E; Del Rio JA Acta Neuropathol; 2020 Apr; 139(4):735-771. PubMed ID: 31907603 [TBL] [Abstract][Full Text] [Related]
32. Volumetric MRI and 1H MRS study of hippocampus in unilateral MCAO patients: relationship between hippocampal secondary damage and cognitive disorder following stroke. Tang X; Wang C; Xia L; Zhu W; Zhao L; Zhu W Eur J Radiol; 2012 Oct; 81(10):2788-93. PubMed ID: 21945401 [TBL] [Abstract][Full Text] [Related]
33. Regional proton magnetic resonance spectroscopy patterns in dementia with Lewy bodies. Graff-Radford J; Boeve BF; Murray ME; Ferman TJ; Tosakulwong N; Lesnick TG; Maroney-Smith M; Senjem ML; Gunter J; Smith GE; Knopman DS; Jack CR; Dickson DW; Petersen RC; Kantarci K Neurobiol Aging; 2014 Jun; 35(6):1483-90. PubMed ID: 24468473 [TBL] [Abstract][Full Text] [Related]
34. Clinicopathologic heterogeneity in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) due to microtubule-associated protein tau (MAPT) p.P301L mutation, including a patient with globular glial tauopathy. Tacik P; Sanchez-Contreras M; DeTure M; Murray ME; Rademakers R; Ross OA; Wszolek ZK; Parisi JE; Knopman DS; Petersen RC; Dickson DW Neuropathol Appl Neurobiol; 2017 Apr; 43(3):200-214. PubMed ID: 27859539 [TBL] [Abstract][Full Text] [Related]
35. (1)H-MRS metabolites in adults with Down syndrome: Effects of dementia. Lin AL; Powell D; Caban-Holt A; Jicha G; Robertson W; Gold BT; Davis R; Abner E; Wilcock DM; Schmitt FA; Head E Neuroimage Clin; 2016; 11():728-735. PubMed ID: 27330972 [TBL] [Abstract][Full Text] [Related]